Insider · CIK 0001965033
Bryce L. Johns
Files at CB (Chubb Ltd). First filing Mar 6, 2026, latest Mar 6, 2026.
In brief
Bryce L. Johns files SEC Form 4 as officer at CB (Chubb Ltd). Since Mar 6, 2026, Bryce L. Johns has reported 0 open-market buys worth $0 and 1 open-market sell worth $505k, the latest filed on Mar 6, 2026.
A track record needs three past buys with six months of prices behind them; Bryce L. Johns has 0, so none is measured yet.
The newest scored trade: sold $505k of CB on Mar 4, 2026, filed Mar 6, 2026, scored 48 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $505k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CB: Chubb Ltd
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | Chubb Ltd | $505k 1,500 shares | -6% | +26% from low-3% from high |
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 21, 2026 | CB Chubb Ltd | DDisposition to issuer Common Shares | -243 | $0.00 | $0 | 24,527 | May 26, 2026 |
| Mar 4, 2026 | CB Chubb Ltd | SOpen-market sale Common Shares | -1,500 | $336.62 | $505k | 24,770 | Mar 6, 2026 |
| Mar 2, 2026 | CB Chubb Ltd | AGrant or award Common Shares | +1,609 | $0.00 | $0 | 23,615 | Mar 4, 2026 |
| Mar 2, 2026 | CB Chubb Ltd | AGrant or award Common Shares | +1,609 | $0.00 | $0 | 25,224 | Mar 4, 2026 |
| Mar 2, 2026 | CB Chubb Ltd | AGrant or award Common Shares | +1,046 | $0.00 | $0 | 26,270 | Mar 4, 2026 |
| Mar 2, 2026 | CB Chubb Ltd | AGrant or award Options to Acquire Common Sharesderivative | +4,289 | $0.00 | $0 | 4,289 | Mar 4, 2026 |
| May 15, 2025 | CB Chubb Ltd | DDisposition to issuer Common Shares | -247 | $0.00 | $0 | 21,916 | May 19, 2025 |
| Mar 3, 2025 | CB Chubb Ltd | AGrant or award Common Shares | +1,748 | $0.00 | $0 | 19,279 | Mar 5, 2025 |
| Mar 3, 2025 | CB Chubb Ltd | AGrant or award Common Shares | +1,748 | $0.00 | $0 | 21,027 | Mar 5, 2025 |
| Mar 3, 2025 | CB Chubb Ltd | AGrant or award Common Shares | +1,136 | $0.00 | $0 | 22,163 | Mar 5, 2025 |
| Mar 3, 2025 | CB Chubb Ltd | AGrant or award Options to Acquire Common Sharesderivative | +4,661 | $0.00 | $0 | 4,661 | Mar 5, 2025 |
| Feb 26, 2024 | CB Chubb Ltd | AGrant or award Common Shares | +1,472 | $0.00 | $0 | 14,995 | Feb 28, 2024 |
| Feb 26, 2024 | CB Chubb Ltd | AGrant or award Common Shares | +1,472 | $0.00 | $0 | 16,467 | Feb 28, 2024 |
| Feb 26, 2024 | CB Chubb Ltd | AGrant or award Common Shares | +957 | $0.00 | $0 | 17,424 | Feb 28, 2024 |
| Feb 26, 2024 | CB Chubb Ltd | AGrant or award Options to Acquire Common Sharesderivative | +3,925 | $0.00 | $0 | 12,627 | Feb 28, 2024 |
Questions about Bryce L. Johns
Answered from the filings on this page, as of the latest one.
Is Bryce L. Johns buying or selling?
In the last 12 months Bryce L. Johns reported 0 open-market buys worth $0 and 1 open-market sell worth $505k on SEC Form 4; the latest was sold $505k of CB on Mar 4, 2026. Grants, option exercises and tax withholding are not counted.
How did Bryce L. Johns's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Bryce L. Johns has 0.
Where does Bryce L. Johns file Form 4?
Bryce L. Johns has filed Form 4 at CB (Chubb Ltd) as Senior Vice President, *. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.